Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HR7P
|
|||
| Former ID |
DNCL002681
|
|||
| Drug Name |
Amonafide
|
|||
| Synonyms |
Quinamed (TN)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 3 | [1] | |
| Ovarian cancer [ICD-11: 2C73; ICD-10: C56] | Phase 3 | [1] | ||
| Prostate cancer [ICD-11: 2C82.0] | Phase 3 | [1] | ||
| Company |
Cephalon
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H17N3O2
|
|||
| Canonical SMILES |
CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N
|
|||
| InChI |
1S/C16H17N3O2/c1-18(2)6-7-19-15(20)12-5-3-4-10-8-11(17)9-13(14(10)12)16(19)21/h3-5,8-9H,6-7,17H2,1-2H3
|
|||
| InChIKey |
UPALIKSFLSVKIS-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 69408-81-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
454647, 649558, 6768979, 7978695, 8137324, 8181622, 11407036, 11447031, 12013383, 14897673, 26732722, 34715068, 49996117, 57313297, 77462411, 93309934, 99437116, 103185920, 103942123, 104294878, 124633549, 124757194, 125163998, 125824374, 126599393, 126622755, 126666546, 126731211, 129400054, 131480857, 135010098, 135584358, 135626809, 135727484, 136342473, 136348800, 136367404, 137156911, 142308824, 143493289, 144115626, 151990150, 152234933, 152258285, 160647124, 160657822, 162037565, 162178779, 163123321, 164835792
|
|||
| ChEBI ID |
CHEBI:94661
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00715637) Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDEStudy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.